Grant: Discovery Grants Program - Individual
McGill University
$128,000.00
Driving Synthesis by Oxidation
EF 2022-23
Résumé
Our group develops technologies to improve the efficiency of chemical synthesis. We specialize in selective catalytic aerobic oxidations that allow us to use molecular oxygen (O2) in complex molecule settings. O2 is used infrequently to synthesize fine and pharmaceutical chemicals because it is prone to radical reactions that can be difficult to control. We avoid these by activating O2 with a transition metal and fine-tuning its reactivity with ligands. O2 is small and has a triplet electronic structure. This makes it difficult to oxidize a molecule in a single position if this position is not electronically differentiated. However, by placing O2 into the confines of a ligand-metal pocket, we change both its size and electronic structure. Using this approach to aerobic catalysis has allowed us to predictably oxidize individual carbon-hydrogen bonds in complex molecules, even when these bonds are not the weakest or most accessible. The environmental benefits of using O2 are attractive, and in the past three years we have partnered with L'Oreal (France) and FPInnovations (Quebec) to apply our catalytic aerobic platforms to their challenges. We are sensitive to the concerns and restrictions of industrial chemists, and focus our innovation on earth abundant metals, simple ligands and practical operations. In the last six years, our program has trained 30 HQP and published > 25 manuscripts, accruing national and international student and young investigator awards.This working environment creates the context for the current NSERC Discovery Grant. Building upon our experience in aerobic catalysis, we will explore two new directions in materials science and medicinal chemistry that will challenge and advance our understanding of oxidation chemistry. The first program explores the bio-polymer melanin, and asks fundamental questions about its structure, properties and function. We are interested in melanin because of its importance to human health, and because melanin-inspired materials hold promise as catalysts, membranes, molecular wires, and sensors. The second program explores oxidation in the very different context of treating neurological disorders. Small-molecule therapies are the most effective ways of managing pain, and treating dementia associated with neurodegeneration, but the recent opiate epidemic makes clear that less addictive alternatives are urgently required. We believe that oxidation reactions can play a critical role in providing new medications with more highly refined properties. These two programs complement our parallel interests in cellulose, hair coloration, stem-cell biology and metal refinement to create an interdisciplinary learning environment with which to train the next generation of Canada's chemists.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-06386
Name nom
Lumb, Jean-Philip
Department département
Chemistry - Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
128000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Driving Synthesis by Oxidation
Application summary
Our group develops technologies to improve the efficiency of chemical synthesis. We specialize in selective catalytic aerobic oxidations that allow us to use molecular oxygen (O2) in complex molecule settings. O2 is used infrequently to synthesize fine and pharmaceutical chemicals because it is prone to radical reactions that can be difficult to control. We avoid these by activating O2 with a transition metal and fine-tuning its reactivity with ligands. O2 is small and has a triplet electronic structure. This makes it difficult to oxidize a molecule in a single position if this position is not electronically differentiated. However, by placing O2 into the confines of a ligand-metal pocket, we change both its size and electronic structure. Using this approach to aerobic catalysis has allowed us to predictably oxidize individual carbon-hydrogen bonds in complex molecules, even when these bonds are not the weakest or most accessible. The environmental benefits of using O2 are attractive, and in the past three years we have partnered with L'Oreal (France) and FPInnovations (Quebec) to apply our catalytic aerobic platforms to their challenges. We are sensitive to the concerns and restrictions of industrial chemists, and focus our innovation on earth abundant metals, simple ligands and practical operations. In the last six years, our program has trained 30 HQP and published > 25 manuscripts, accruing national and international student and young investigator awards.This working environment creates the context for the current NSERC Discovery Grant. Building upon our experience in aerobic catalysis, we will explore two new directions in materials science and medicinal chemistry that will challenge and advance our understanding of oxidation chemistry. The first program explores the bio-polymer melanin, and asks fundamental questions about its structure, properties and function. We are interested in melanin because of its importance to human health, and because melanin-inspired materials hold promise as catalysts, membranes, molecular wires, and sensors. The second program explores oxidation in the very different context of treating neurological disorders. Small-molecule therapies are the most effective ways of managing pain, and treating dementia associated with neurodegeneration, but the recent opiate epidemic makes clear that less addictive alternatives are urgently required. We believe that oxidation reactions can play a critical role in providing new medications with more highly refined properties. These two programs complement our parallel interests in cellulose, hair coloration, stem-cell biology and metal refinement to create an interdisciplinary learning environment with which to train the next generation of Canada's chemists.